Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Letter to the Editor

Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April)

Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia

Authors

Mike Makris , Cedric Hermans

Key words: Cryoprecipitate, FVIII concentrate, Haemophilia, Transfusion transmitted infection, World Health Organisation
Doi: 10.2450/BloodTransfus.974
Hemostasis and thrombosis
Publication Date: 2025-01-21

Abstract

This letter to the editor challenges the inclusion of cryoprecipitate on the WHO list of essential medicines to treat haemophilia.

References

Downloads

pdf
Authors

Mike Makris School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom

Cedric Hermans Division of Haematology, Haemostasis and Thrombosis Unit, Saint-Luc University Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium

  • Abstract viewed - 774 times
  • pdf downloaded - 0 times